Evidence map›Paper›PMID 39247846›Full record

ArticleIEEE journal of translational engineering in health and medicine2024

Deep Learning and fMRI-Based Pipeline for Optimization of Deep Brain Stimulation During Parkinson's Disease Treatment: Toward Rapid Semi-Automated Stimulation Optimization.

Jianwei Qiu, Afis Ajala, John Karigiannis, Jurgen Germann, Brendan Santyr, Aaron Loh, Luca Marinelli, Thomas Foo, Radhika Madhavan, Desmond Yeo and 2 more

Abstract read
In one paragraph

Article in IEEE journal of translational engineering in health and medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Explainability in AI-enabled medical neurotechnology: a scoping review.Journal of neuroengineering and rehabilitation · 2026
    Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Jianwei QiuGE HealthCare Technology & Innovation Center Niskayuna NY 12309 USA.ORCID 0000-0002-2315-143X
Afis AjalaGE HealthCare Technology & Innovation Center Niskayuna NY 12309 USA.ORCID 0000-0002-1763-0274
John KarigiannisGE Global Research Niskayuna NY 12309 USA.
Jurgen GermannDivision of NeurosurgeryDepartment of SurgeryUniversity Health Network Toronto ON M5G 2C4 Canada.
Brendan SantyrDivision of NeurosurgeryDepartment of SurgeryUniversity Health Network Toronto ON M5G 2C4 Canada.ORCID 0000-0003-1782-4527
Aaron LohDivision of NeurosurgeryDepartment of SurgeryUniversity Health Network Toronto ON M5G 2C4 Canada.
Luca MarinelliGE HealthCare Technology & Innovation Center Niskayuna NY 12309 USA.
Thomas FooGE HealthCare Technology & Innovation Center Niskayuna NY 12309 USA.
Radhika MadhavanGE HealthCare Technology & Innovation Center Niskayuna NY 12309 USA.
Desmond YeoGE HealthCare Technology & Innovation Center Niskayuna NY 12309 USA.
Alexandre BoutetDivision of NeurosurgeryDepartment of SurgeryUniversity Health Network Toronto ON M5G 2C4 Canada.ORCID 0000-0001-6942-5195
Andres LozanoDivision of NeurosurgeryDepartment of SurgeryUniversity Health Network Toronto ON M5G 2C4 Canada.

Funding

Functional Magnetic Resonance Imaging and Deep Learning to Improve Deep Brain Stimulation TherapyR01NS133433 · NINDS · GENERAL ELECTRIC GLOBAL RESEARCH CTR · PI Afis Ajala · 2023 to 2026
$1.7M
NINDS NIH HHS R01 NS133433
6 · The paper itself

Abstract

objectiveOptimized deep brain stimulation (DBS) is fast becoming a therapy of choice for the treatment of Parkinson's disease (PD). However, the post-operative optimization (aimed at maximizing patient clinical benefits and minimizing adverse effects) of all possible DBS parameter settings using the standard-of-care clinical protocol requires numerous clinical visits, which substantially increases the time to optimization per patient (TPP), patient cost burden and limit the number of patients who can undergo DBS treatment. The TPP is further elongated in electrodes with stimulation directionality or in diseases with latency in clinical feedback. In this work, we proposed a deep learning and fMRI-based pipeline for DBS optimization that can potentially reduce the TPP from ~1 year to a few hours during a single clinical visit. METHODS AND PROCEDURES: We developed an unsupervised autoencoder (AE)-based model to extract meaningful features from 122 previously acquired blood oxygenated level dependent (BOLD) fMRI datasets from 39 a priori clinically optimized PD patients undergoing DBS therapy. The extracted features are then fed into multilayer perceptron (MLP)-based parameter classification and prediction models for rapid DBS parameter optimization.

resultsThe AE-extracted features of optimal and non-optimal DBS were disentangled. The AE-MLP classification model yielded accuracy, precision, recall, F1 score, and combined AUC of 0.96 ± 0.04, 0.95 ± 0.07, 0.92 ± 0.07, 0.93 ± 0.06, and 0.98 respectively. Accuracies of 0.79 ± 0.04, 0.85 ± 0.04, 0.82 ± 0.05, 0.83 ± 0.05, and 0.70 ± 0.07 were obtained in the prediction of voltage, frequency, and x-y-z contact locations, respectively.

conclusionThe proposed AE-MLP models yielded promising results for fMRI-based DBS parameter classification and prediction, potentially facilitating rapid semi-automated DBS parameter optimization. Clinical and Translational Impact Statement-A deep learning-based pipeline for semi-automated DBS parameter optimization is presented, with the potential to significantly decrease the optimization duration per patient and patients' financial burden while increasing patient throughput.

Indexed as

Deep Brain StimulationDeep LearningMagnetic Resonance ImagingParkinson DiseaseAgedBrainFemaleHumansImage Processing, Computer-AssistedMaleMiddle AgedDeep brain stimulation optimizationdeep learningfMRIParkinson’s diseaseunsupervised feature extraction.

Identifiers

PMID39247846
PMCPMC11379443

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.